Sipher USD Price & Performance (SIPHERUSD)

Cipher Pharmaceuticals experienced a significant boost as Leede Financial upgraded its stock rating to “Buy.” This follows strong Q4 results, with revenue up 141% year-over-year. The company’s acquisition of Natroba has positioned it for further growth, and analysts forecast a 21% return, maintaining a price target of $14.50.1

XRP’s price soared 30% after the conclusion of its legal battle with the SEC. Investors are optimistic about the cryptocurrency’s future, with projections suggesting a potential 75% rally. This marks a significant turning point for XRP, which has faced prolonged regulatory scrutiny in recent years.2